登录 注册 会员服务 联系我们

Informing the Choice of Direct Oral Anticoagulant Therapy in Patients With Atrial Fibrillation

  • Published:2021-12-21 Issue:23 Volume:326 Page:2372
  • ISSN:0098-7484
  • Container-title:JAMA
  • language:en
  • Short-container-title:JAMA

Author:

Ferro Enrico G.123,Kazi Dhruv S.123,Zimetbaum Peter J.1234

Affiliation:

1. Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts

2. Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts

3. Harvard Medical School, Boston, Massachusetts

4. Harvard Thorndike Arrhythmia Service, Beth Israel Deaconess Medical Center, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

General Medicine

Reference17 articles.

1. Thromboembolism associated with auricular fibrillation: continuous anticoagulant therapy.;Askey;JAMA,1950

2. National trends in use of and spending on oral anticoagulants among US Medicare beneficiaries from 2011 to 2019.;Troy;JAMA Health Forum,2021

3. Association of rivaroxaban vs apixaban with major ischemic or hemorrhagic events in patients with atrial fibrillation.;Ray;JAMA,2021

4. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.;Patel;N Engl J Med,2011

5. Apixaban versus warfarin in patients with atrial fibrillation.;Granger;N Engl J Med,2011

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3